SCHEMBL30006963

SCHEMBL30006963

Cc1nc(O)c2cc(P(C)(C)=O)ncc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27093801 1.00 — —
SCHEMBL30878232 0.75 PIK3CD (0.32) —
SCHEMBL30754558 0.73 TOP1 (0.32) —
SCHEMBL27093848 0.73 TOP1 (0.32) —
SCHEMBL21494875 0.73 KRAS (0.33) —
SCHEMBL24800366 0.73 ALDH1A1 (0.35) —
SCHEMBL31115646 0.73 — —
SCHEMBL29863061 0.73 KRAS (0.33) —
SCHEMBL31115650 0.73 TDP1 (0.36) —
SCHEMBL21494905 0.71 KRAS (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4602049-A1 SOS1 INHIBITORS Bayer Aktiengesellschaft (DE) 2025-08-20 — — EP disclosed
EP-4322962-A1 PHOSPHORUS DERIVATIVES AS NOVEL SOS1 INHIBITORS Bayer Aktiengesellschaft (DE) 2024-02-21 — — EP disclosed
CN-117500507-A Phosphorus derivatives as novel SOS1 inhibitors 拜耳公司 2024-02-02 — — CN disclosed
WO-2022219035-A1 PHOSPHORUS DERIVATIVES AS NOVEL SOS1 INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2022-10-20 — — WO disclosed
Send feedback